Photo By: Myriam Zilles from Unsplash

I don’t know about you, but I have completely checked out on COVID-19 news in recent weeks. With most of life reopened, and having received both doses of the vaccination back in the summer, I’ve been grateful to be able to largely disengage with the daily updates.

However, there was a recent piece of news that certainly caught my eye. More specifically, a treatment for COVID-19, called molnupiravir, has performed well in recent clinical trials at reducing the effects of the virus. 

We know by now that having effective clinical treatments for COVID-19 that are readily available is going to be critical if we want life to return to normal. While folks like Joe Rogan have no issue paying out the nose to try every treatment for COVID-19 under the sun, including the controversial ivermectin, those of us who aren’t multi-millionaires don’t have that luxury.

That’s why something like molnupiravir is so important. Currently, it’s the only treatment for COVID-19 that can be taken in a pill form, all others must be injected or taken through an IV. What this should mean in practice is that it will be far more affordable and attainable for us common folks.

That is the key to not just fighting the pandemic, but finally nailing its coffin shut once and for all. We know that COVID-19 is likely to live with us now forever, we also know that the vaccines do not stop you from contracting or spreading the virus, but seem to more so act as somewhat of a “preventative treatment.” With that said, that’s why we need treatments like molnupiravir if we want life to fully return to normal, because that way, we will be able to treat COVID-19 like any other viral infection; you contract it, get diagnosed, get prescribed molnupiravir, and you’re back on your feet in less than a week.

But if the pandemic has done anything, it’s increased my already strong pessimistic tendencies, so let’s make sure we temper our expectations, shall we? While this new treatment has been tested, it has not been peer-reviewed, and Health Canada has made it clear that they are in no rush to approve it. So in all likelihood we are a long way away from seeing molnupiravir in regular use.

Despite my cynical nature, I can’t help but be excited by the recent advancement in COVID-19 treatments. While I understand that the goalpost has been moved countless times on how to properly “end the pandemic,” we can attribute that to the fact that nobody had any idea how it would actually play out until it happened, so all information on the pandemic is constantly evolving.

With that said though, I am as optimistic as I can be (which admittedly, is not very optimistic) about what it would mean to have reliable, pharmaceutical treatments to COVID-19. That, plus being vaccinated, really should be the death knell for this thing.

But I’m not a scientist, just a liberal arts major (about the farthest thing from a scientist) so what do I know? At the end of the day this is just a semi-educated guess. Even with all that said, I can’t help but think that treatments like molnupiravir may mark the end of this pandemic era.